Azienda Ospedaliero Universitaria Senese
Azienda Ospedaliero Universitaria Senese
Siena, Italy4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-09-25 | NCT05623020 | |
| Pirfenidone to Prevent Fibrosis in Ards. | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, adult acute respiratory distress syndrome, interstitial lung disease, lung disorder, pulmonary fibrosis, respiratory system disorder | Recruiting | Phase 3 | 2026-05-08 | NCT05075161 | |
| A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma | Advanced Melanoma | Active, not recruiting | Phase 2 | 2026-01-16 | NCT05529316 | |
| PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections | Antimicrobial Resistance (AMR); Gram Negative Infection | Recruiting | Not stated | 2024-10-21 | NCT06651047 |